Follow
Richard Hift
Richard Hift
Professor of medicine, university of kwazulu-natal
Verified email at ukzn.ac.za
Title
Cited by
Cited by
Year
C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload
SD Whatley, S Ducamp, L Gouya, B Grandchamp, C Beaumont, ...
The American Journal of Human Genetics 83 (3), 408-414, 2008
3052008
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria
PN Meissner, TA Dailey, RJ Hift, M Ziman, AV Corrigall, AG Roberts, ...
Nature genetics 13 (1), 95-97, 1996
2431996
The acute porphyrias
GH Elder, RJ Hift, PN Meissner
The Lancet 349 (9065), 1613-1617, 1997
2251997
An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity
RJ Hift, PN Meissner
Medicine 84 (1), 48-60, 2005
1872005
Liver disease in erythropoietic protoporphyria: insights and implications for management
AV Anstey, RJ Hift
Postgraduate medical journal 83 (986), 739-748, 2007
1612007
Porphyrias
MFM James, RJ Hift
British Journal of Anaesthesia 85 (1), 143-153, 2000
1572000
Should essays and other “open-ended”-type questions retain a place in written summative assessment in clinical medicine?
RJ Hift
BMC Medical Education 14, 1-18, 2014
1272014
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non‐melanoma skin cancer in an at‐risk population: a cohort study
M Setshedi, D Epstein, TA Winter, L Myer, G Watermeyer, R Hift
Journal of gastroenterology and hepatology 27 (2), 385-389, 2012
1182012
Variegate porphyria
RE Kirsch, PN Meissner, RJ Hift
Seminars in liver disease 18 (01), 33-41, 1998
1011998
A structured assessment of newly qualified medical graduates
VC Burch, RC Nash, T Zabow, T Gibbs, L Aubin, B Jacobs, RJ Hift
Medical education 39 (7), 723-731, 2005
902005
Women's perceptions of the benefits and risks of skin‐lightening creams in two South African communities
N Dlova, SH Hamed, J Tsoka‐Gwegweni, A Grobler, R Hift
Journal of cosmetic dermatology 13 (3), 236-241, 2014
832014
Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of …
RJ Hift, BP Davidson, C van der Hooft, DM MEIssNER, PN Meissner
Clinical chemistry 50 (5), 915-923, 2004
792004
Homozygous variegate porphyria: an evolving clinical syndrome
RJ Hift, PN Meissner, G Todd, P Kirby, D Bilsland, P Collins, J Ferguson, ...
Postgraduate medical journal 69 (816), 781-786, 1993
721993
Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity
RJ Hift, S Thunell, A Brun
Pharmacology & therapeutics 132 (2), 158-169, 2011
702011
Anaesthesia for the porphyric patient
GG Harrison, PN Meissner, RJ Hift
Anaesthesia 48 (5), 417-421, 1993
681993
South African medical schools: current state of selection criteria and medical students’ demographic profile
LJ Van der Merwe, GJ Van Zyl, ASC Gibson, A Viljoen, JE Iputo, ...
South African Medical Journal 106 (1), 76-81, 2016
672016
The spectrum of skin diseases in a black population in D urban, K waZulu‐Natal, S outh Africa
NC Dlova, A Mankahla, N Madala, A Grobler, J Tsoka‐Gwegweni, RJ Hift
International journal of dermatology 54 (3), 279-285, 2015
652015
Treatment of acute porphyria
GH Elder, RJ Hift
Hospital Medicine 62 (7), 422-425, 2001
582001
Drugs in the acute porphyrias--toxicogenetic diseases.
MR Moore, RJ Hift
Cellular and Molecular Biology (Noisy-le-Grand, France) 43 (1), 89-94, 1997
561997
A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’
RJ Hift, TJ Peters, PN Meissner
Journal of clinical pathology 65 (3), 200-205, 2012
532012
The system can't perform the operation now. Try again later.
Articles 1–20